Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/4738
Title: An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity
Authors: Ferreiro, Elisabete 
Resende, Rosa 
Costa, Rui 
Oliveira, Catarina R. 
Pereira, Cláudia M.F. 
Keywords: Prion disorders; Alzheimer's disease; Prion peptide; Amyloid-β peptide; Apoptosis; Ca2+ homeostasis; Endoplasmic reticulum; Oxidative stress
Issue Date: 2006
Citation: Neurobiology of Disease. 23:3 (2006) 669-678
Abstract: Prion (PrP) and amyloid-[beta] (A[beta]) peptides are involved in the neuronal loss that occurs in Prion disorders (PrD) and Alzheimer's disease (AD), respectively, partially due to Ca2+ dysregulation. Besides, the endoplasmic reticulum (ER) stress has an active role in the neurotoxic mechanisms that lead to these pathologies. Here, we analyzed whether the ER-mediated apoptotic pathway is involved in the toxic effect of synthetic PrP and A[beta] peptides. In PrP106-126- and A[beta]1-40-treated cortical neurons, the release of Ca2+ through ER ryanodine (RyR) and inositol 1,4,5-trisphosphate (IP3R) receptors induces ER stress and leads to increased cytosolic Ca2+ and reactive oxygen species (ROS) levels and subsequently to apoptotic death involving mitochondrial cytochrome c release and caspases activation. These results demonstrate that the early PrP- and A[beta]-induced perturbation of ER Ca2+ homeostasis is a death message that leads to neuronal loss, suggesting that the regulation of ER Ca2+ levels may be a potential therapeutical target for PrD and AD.
URI: http://hdl.handle.net/10316/4738
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
fileabfe60f7eb304f3d83050c336c1d4af0.pdf529.35 kBAdobe PDFView/Open
Show full item record

Page view(s) 50

328
checked on Feb 24, 2020

Download(s) 20

734
checked on Feb 24, 2020

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.